Crutch, SJ;
              
      
            
                Schott, JM;
              
      
            
                Rabinovici, GD;
              
      
            
                Murray, M;
              
      
            
                Snowden, JS;
              
      
            
                van der Flier, WM;
              
      
            
                Dickerson, BC;
              
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
            ... Alzheimer's Association ISTAART Atypical Alzheimer's Disease and, .; + view all
            
          
      
        
        
        
    
  
(2017)
  Consensus classification of posterior cortical atrophy.
Alzheimer's & Dementia
      
    
    
    
         10.1016/j.jalz.2017.01.014.
   (In press).
  
       
    
  
| Preview | Text 1-s2.0-S1552526017300407-main.pdf - Published Version Download (2MB) | Preview | 
Abstract
INTRODUCTION: A classification framework for posterior cortical atrophy (PCA) is proposed to improve the uniformity of definition of the syndrome in a variety of research settings. METHODS: Consensus statements about PCA were developed through a detailed literature review, the formation of an international multidisciplinary working party which convened on four occasions, and a Web-based quantitative survey regarding symptom frequency and the conceptualization of PCA. RESULTS: A three-level classification framework for PCA is described comprising both syndrome- and disease-level descriptions. Classification level 1 (PCA) defines the core clinical, cognitive, and neuroimaging features and exclusion criteria of the clinico-radiological syndrome. Classification level 2 (PCA-pure, PCA-plus) establishes whether, in addition to the core PCA syndrome, the core features of any other neurodegenerative syndromes are present. Classification level 3 (PCA attributable to AD [PCA-AD], Lewy body disease [PCA-LBD], corticobasal degeneration [PCA-CBD], prion disease [PCA-prion]) provides a more formal determination of the underlying cause of the PCA syndrome, based on available pathophysiological biomarker evidence. The issue of additional syndrome-level descriptors is discussed in relation to the challenges of defining stages of syndrome severity and characterizing phenotypic heterogeneity within the PCA spectrum. DISCUSSION: There was strong agreement regarding the definition of the core clinico-radiological syndrome, meaning that the current consensus statement should be regarded as a refinement, development, and extension of previous single-center PCA criteria rather than any wholesale alteration or redescription of the syndrome. The framework and terminology may facilitate the interpretation of research data across studies, be applicable across a broad range of research scenarios (e.g., behavioral interventions, pharmacological trials), and provide a foundation for future collaborative work.
| Type: | Article | 
|---|---|
| Title: | Consensus classification of posterior cortical atrophy | 
| Location: | United States | 
| Open access status: | An open access version is available from UCL Discovery | 
| DOI: | 10.1016/j.jalz.2017.01.014 | 
| Publisher version: | http://doi.org/10.1016/j.jalz.2017.01.014 | 
| Language: | English | 
| Additional information: | © 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | 
| Keywords: | Alzheimer's disease, Biomarker, Clinico-radiological syndrome, Pathophysiology, Posterior cortical atrophy | 
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases | 
| URI: | https://discovery.ucl.ac.uk/id/eprint/1544187 | 
Archive Staff Only
|  | View Item | 
 
                      
